Why GlaxoSmithKline plc, Severn Trent Plc And Enterprise Inns plc Should Lag The FTSE 100 Today

GlaxoSmithKline plc (LON: GSK), Severn Trent Plc (LON: SVT) and Enterprise Inns plc (LON: ETI) all fall.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) perked up a bit on opening this morning, but quickly fell back to hover around yesterday’s close. By late morning it’s eight points up at 6,483. But that’s 70 points up on the week, and if the trend continues through tomorrow we’ll see the FTSE break out of its four-week losing streak.

Some of our biggest companies aren’t helping, mind, with their share prices falling. Here are three from the various indices dropping today:

GlaxoSmithKline

News of a disappointing clinical drug trial result sent GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) shares down 28.5p (1.7%) to 1,638p this morning. An independent trial of the company’s MAGE-A3 cancer immunotherapeutic treatment “did not meet its first co-primary endpoint as it did not significantly extend disease-free survival“.

Further trials will now he carried out to determine if the drug has benefits for any subset of MAGE-A3 positive patients, with results expected in 2015.

Severn Trent

Water and sewage firm Severn Trent (LSE: SVT) said today that it will not seek an Ofwat review of its 2010-2015 price limits in relation to costs associated with the adoption of private drains and sewers in October 2011. The costs incurred were not included in the set limits, and will now be absorbed by Severn Trent and not passed on to customers.

The shares responded with a fairly modest fall, of 12p (0.7%) to 1,686p, leaving the price pretty much unchanged over the past 12 months. But even with no price appreciation, shareholders are benefiting from dividends yielding around 4.5%.

Enterprise Inns

Shares in Enterprise Inns (LSE: ETI) dropped 3.5p (2.4%) to 142p after the tenanted pub operator told us of a plan to take on more debt. The firm intends to issue approximately £100 million of unsecured guaranteed convertible bonds in order to provide “low cost, unsecured long-term funding” and reduce the firm’s overall cost of borrowing.

Although the shares are down today, they’re still up around 150% over the past 12 months, with a recovery in earnings not expected before 2014.

Finally, you can compensate for the day-to-day ups and downs of share prices by looking for reliable dividends. So how would you like a company that’s offering a 5% yield and which could be set for some nice share-price appreciation, too?

All you need to do is get a copy of our BRAND-NEW report, “The Motley Fool’s Top Income Share” — it’s completely free of charge, but it will only be available for a limited period. Click here to enjoy your copy today.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »